SCHEMBL257371

SCHEMBL257371

Cc1ccc(C(=O)c2ccccc2F)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
GAA P10253 3/20 0.51
MEN1 O00255 3/20 0.51
ALDH1A1 P00352 4/20 0.50
POLB P06746 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
ALOX15 P16050 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
MAPT P10636 2/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
ABCC9 O60706 1/20 0.43
ABCC8 Q09428 1/20 0.43
KCNJ11 Q14654 1/20 0.43
KCNJ8 Q15842 1/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GMNN O75496 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15100602 0.85 ALDH1A1 (0.54) KMT2AMEN1ALDH1A1POLBSLC6A2
SCHEMBL15197083 0.85 ALDH1A1 (0.68) KMT2AGAAMEN1ALDH1A1POLB
SCHEMBL15197147 0.83 ALDH1A1 (0.46) KMT2AGAAMEN1ALDH1A1POLB
SCHEMBL10046987 0.83 CES2 (0.47) KMT2ACES2CES1HPGDCYP3A4
SCHEMBL10046979 0.83 ALDH1A1 (0.43) ALDH1A1SLC6A2SLC6A4SLC6A3MAPT
SCHEMBL11550449 0.83 ALDH1A1 (0.73) KMT2AALDH1A1POLBKDM4ELMNA
SCHEMBL15197122 0.83 ALDH1A1 (0.54) KMT2AGAAMEN1ALDH1A1ALOX15
SCHEMBL17235790 0.82 ALDH1A1 (0.48) KMT2AGAAMEN1ALDH1A1POLB
SCHEMBL15100878 0.81 SMN1; SMN2 (0.48) KMT2AGAAMEN1ALDH1A1POLB
SCHEMBL10047113 0.80 KMT2A (0.51) KMT2AGAAMEN1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 KMT2A 1199/4885GAA 4354/4885MEN1 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.